Trial Profile
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects with Phenylketonuria Who Have Elevated Phenylalanine Levels
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2019
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Therapeutic Use
- Sponsors BioMarin Pharmaceutical
- 26 Jun 2019 Status changed from recruiting to completed.
- 21 Jul 2014 New trial record